Nanomedicine-based strategies for the treatment of vein graft disease
- 5 November 2024
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 22 (4) , 255-272
Abstract
Autologous saphenous veins are the most frequently used conduits for coronary and peripheral artery bypass grafting. However, vein graft failure rates of 40–50% within 10 years of the implantation lead to poor long-term outcomes after bypass surgery. Currently, only a few therapeutic approaches for vein graft disease have been successfully translated into clinical practice. Building on the past two decades of advanced understanding of vein graft biology and the pathophysiological mechanisms underlying vein graft disease, nanomedicine-based strategies offer promising opportunities to address this important unmet clinical need. In this Review, we provide deep insight into the latest developments in the rational design and applications of nanoparticles that have the potential to target specific cells during various pathophysiological stages of vein graft disease, including early endothelial dysfunction, intermediate intimal hyperplasia and late-stage accelerated atherosclerosis. Additionally, we underscore the convergence of nanofabricated biomaterials, with a particular focus on hydrogels, external graft support devices and cell-based therapies, alongside bypass surgery to improve local delivery efficiency and therapeutic efficacy. Finally, we provide a specific discussion on the considerations, challenges and novel perspectives for the future clinical translation of nanomedicine for the treatment of vein graft disease.Keywords
This publication has 229 references indexed in Scilit:
- Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft SurgeryJAMA, 2022
- External Support for Saphenous Vein Grafts in Coronary Artery Bypass SurgeryJAMA Cardiology, 2022
- Mouse models of atherosclerosis and their suitability for the study of myocardial infarctionBasic Research in Cardiology, 2020
- Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass GraftingJAMA, 2018
- Recent Advances in Managing Atherosclerosis via NanomedicineSmall, 2017
- Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular DiseaseJAMA Cardiology, 2016
- Smooth muscle cells from the anastomosed artery are the major precursors for neointima formation in both artery and vein graftsBasic Research in Cardiology, 2014
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft SurgeryJAMA, 2005
- New Stent for Support of Veins in Arterial GraftsArchives of Surgery, 1963